Hey guys,
Just an update on all the Costraelis stuff. This is what I've found:
There are currently THREE selective CRTH2 antagonists being investigated:
1) AM-211 by Amira Pharmaceuticals
2) AM-156 by Amira Pharmaceuticals
3) MK-7246 by Merck Pharmaceuticals!
Now, Phase I for MK-7246 in Asthma has already been completed! They're also developing other analogues of MK-7246 as back up in case MK-7246 is not effective in Phase IIa trials.
This all sounds very promising and let's hope it proves safe to be used! The future is looking brighter every day
Just an update on all the Costraelis stuff. This is what I've found:
There are currently THREE selective CRTH2 antagonists being investigated:
1) AM-211 by Amira Pharmaceuticals
2) AM-156 by Amira Pharmaceuticals
3) MK-7246 by Merck Pharmaceuticals!
Now, Phase I for MK-7246 in Asthma has already been completed! They're also developing other analogues of MK-7246 as back up in case MK-7246 is not effective in Phase IIa trials.
This all sounds very promising and let's hope it proves safe to be used! The future is looking brighter every day

Comment